Taiwan-U.S. Joint R&D Funding Opportunity
Opportunity of up to $250,000 per u.s. company
Supports joint R&D, technology validation, pilot production, and commercialization, with the aim of establishing strategic partnerships between U.S. and Taiwanese companies.
Focus areas include healthcare, biotech, AI, digital technology, semiconductors, advanced materials, and clean energy.
U.S. companies should have a prototype or early data and an identifiable commercialization need.
Funding of up to $250,000 per project may be available to U.S. companies.
A Taiwanese company serves as the lead applicant; therefore, a Taiwan-based partner is required.
Projects may run for up to 18 months.
The initial application deadline may be as early as December 30, 2026.
Next Steps
Submit your company information below to be considered for an introduction to a Taiwan-based company.
Submissions will be shared with my contact in Taiwan for potential partnership consideration.
Companies identified as potential matches will be invited to a 30-minute introductory call to discuss the opportunity, partnership alignment, eligibility, and application requirements.
Interested companies can then determine whether to pursue a joint application.
Program details and requirements are based on currently available information and may be subject to clarification or change.
contact@pantherin.ai